Mitochondria may hold the key to sex-specific therapies that improve long-term heart health for babies
As many as 20 per cent of pregnancies are affected by complications that can lead to long-term heart problems for babies. A common complication, called fetal hypoxia, occurs when the fetus does not receive enough oxygen in the womb.
Postdoctoral fellow Murilo Graton is examining the role that mitochondria—the energy source to nearly all of our cells—may play in the relationship between fetal hypoxia and impaired cardiovascular health in adulthood. He aims to extend existing scientific knowledge that could ultimately lead to early-targeted and sex-specific therapies that will improve children’s health outcomes later in life.